EQUIPT

Protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control

Subhash Pokhrel, Silvia Evers, Reiner Leidl, Marta Trapero-Bertran, Z. Kaló, Hein De Vries, Andrea Crossfield, Fiona Andrews, Ailsa Rutter, Kathryn Coyle, Adam Lester-George, Robert West, Lesley Owen, Teresa Jones, Matthias Vogl, Cornel Radu-Loghin, Z. Vokó, Mirjana Huic, Doug Coyle

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Introduction: Tobacco smoking claims 700 000 lives every year in Europe and the cost of tobacco smoking in the EU is estimated between €98 and €130 billion annually; direct medical care costs and indirect costs such as workday losses each represent half of this amount. Policymakers all across Europe are in need of bespoke information on the economic and wider returns of investing in evidence-based tobacco control, including smoking cessation agendas. EQUIPT is designed to test the transferability of one such economic evidence base-the English Tobacco Return on Investment (ROI) tool-to other EU member states.

Methods and analysis: EQUIPT is a multicentre, interdisciplinary comparative effectiveness research study in public health. The Tobacco ROI tool already developed in England by the National Institute for Health and Care Excellence (NICE) will be adapted to meet the needs of European decision-makers, following transferability criteria. Stakeholders' needs and intention to use ROI tools in sample countries (Germany, Hungary, Spain and the Netherlands) will be analysed through interviews and surveys and complemented by secondary analysis of the contextual and other factors. Informed by this contextual analysis, the next phase will develop country-specific ROI tools in sample countries using a mix of economic modelling and Visual Basic programming. The results from the country-specific ROI models will then be compared to derive policy proposals that are transferable to other EU states, from which a centralised web tool will be developed. This will then be made available to stakeholders to cater for different decision-making contexts across Europe.

Ethics and dissemination: The Brunel University Ethics Committee and relevant authorities in each of the participating countries approved the protocol. EQUIPT has a dedicated work package on dissemination, focusing on stakeholders' communication needs. Results will be disseminated via peer-reviewed publications, e-learning resources and policy briefs.

Original languageEnglish
Article numbere006945
JournalBMJ Open
Volume4
Issue number11
DOIs
Publication statusPublished - 2014

Fingerprint

Comparative Effectiveness Research
Tobacco
Economics
Smoking
Costs and Cost Analysis
Ethics Committees
Hungary
National Institutes of Health (U.S.)
Smoking Cessation
Ethics
England
Health Care Costs
Netherlands
Spain
Germany
Publications
Decision Making
Public Health
Communication
Learning

ASJC Scopus subject areas

  • Medicine(all)

Cite this

EQUIPT : Protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. / Pokhrel, Subhash; Evers, Silvia; Leidl, Reiner; Trapero-Bertran, Marta; Kaló, Z.; De Vries, Hein; Crossfield, Andrea; Andrews, Fiona; Rutter, Ailsa; Coyle, Kathryn; Lester-George, Adam; West, Robert; Owen, Lesley; Jones, Teresa; Vogl, Matthias; Radu-Loghin, Cornel; Vokó, Z.; Huic, Mirjana; Coyle, Doug.

In: BMJ Open, Vol. 4, No. 11, e006945, 2014.

Research output: Contribution to journalArticle

Pokhrel, S, Evers, S, Leidl, R, Trapero-Bertran, M, Kaló, Z, De Vries, H, Crossfield, A, Andrews, F, Rutter, A, Coyle, K, Lester-George, A, West, R, Owen, L, Jones, T, Vogl, M, Radu-Loghin, C, Vokó, Z, Huic, M & Coyle, D 2014, 'EQUIPT: Protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control', BMJ Open, vol. 4, no. 11, e006945. https://doi.org/10.1136/bmjopen-2014-006945
Pokhrel, Subhash ; Evers, Silvia ; Leidl, Reiner ; Trapero-Bertran, Marta ; Kaló, Z. ; De Vries, Hein ; Crossfield, Andrea ; Andrews, Fiona ; Rutter, Ailsa ; Coyle, Kathryn ; Lester-George, Adam ; West, Robert ; Owen, Lesley ; Jones, Teresa ; Vogl, Matthias ; Radu-Loghin, Cornel ; Vokó, Z. ; Huic, Mirjana ; Coyle, Doug. / EQUIPT : Protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. In: BMJ Open. 2014 ; Vol. 4, No. 11.
@article{671056e31f4a40c9ad92ae613b73d4dd,
title = "EQUIPT: Protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control",
abstract = "Introduction: Tobacco smoking claims 700 000 lives every year in Europe and the cost of tobacco smoking in the EU is estimated between €98 and €130 billion annually; direct medical care costs and indirect costs such as workday losses each represent half of this amount. Policymakers all across Europe are in need of bespoke information on the economic and wider returns of investing in evidence-based tobacco control, including smoking cessation agendas. EQUIPT is designed to test the transferability of one such economic evidence base-the English Tobacco Return on Investment (ROI) tool-to other EU member states.Methods and analysis: EQUIPT is a multicentre, interdisciplinary comparative effectiveness research study in public health. The Tobacco ROI tool already developed in England by the National Institute for Health and Care Excellence (NICE) will be adapted to meet the needs of European decision-makers, following transferability criteria. Stakeholders' needs and intention to use ROI tools in sample countries (Germany, Hungary, Spain and the Netherlands) will be analysed through interviews and surveys and complemented by secondary analysis of the contextual and other factors. Informed by this contextual analysis, the next phase will develop country-specific ROI tools in sample countries using a mix of economic modelling and Visual Basic programming. The results from the country-specific ROI models will then be compared to derive policy proposals that are transferable to other EU states, from which a centralised web tool will be developed. This will then be made available to stakeholders to cater for different decision-making contexts across Europe.Ethics and dissemination: The Brunel University Ethics Committee and relevant authorities in each of the participating countries approved the protocol. EQUIPT has a dedicated work package on dissemination, focusing on stakeholders' communication needs. Results will be disseminated via peer-reviewed publications, e-learning resources and policy briefs.",
author = "Subhash Pokhrel and Silvia Evers and Reiner Leidl and Marta Trapero-Bertran and Z. Kal{\'o} and {De Vries}, Hein and Andrea Crossfield and Fiona Andrews and Ailsa Rutter and Kathryn Coyle and Adam Lester-George and Robert West and Lesley Owen and Teresa Jones and Matthias Vogl and Cornel Radu-Loghin and Z. Vok{\'o} and Mirjana Huic and Doug Coyle",
year = "2014",
doi = "10.1136/bmjopen-2014-006945",
language = "English",
volume = "4",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - EQUIPT

T2 - Protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control

AU - Pokhrel, Subhash

AU - Evers, Silvia

AU - Leidl, Reiner

AU - Trapero-Bertran, Marta

AU - Kaló, Z.

AU - De Vries, Hein

AU - Crossfield, Andrea

AU - Andrews, Fiona

AU - Rutter, Ailsa

AU - Coyle, Kathryn

AU - Lester-George, Adam

AU - West, Robert

AU - Owen, Lesley

AU - Jones, Teresa

AU - Vogl, Matthias

AU - Radu-Loghin, Cornel

AU - Vokó, Z.

AU - Huic, Mirjana

AU - Coyle, Doug

PY - 2014

Y1 - 2014

N2 - Introduction: Tobacco smoking claims 700 000 lives every year in Europe and the cost of tobacco smoking in the EU is estimated between €98 and €130 billion annually; direct medical care costs and indirect costs such as workday losses each represent half of this amount. Policymakers all across Europe are in need of bespoke information on the economic and wider returns of investing in evidence-based tobacco control, including smoking cessation agendas. EQUIPT is designed to test the transferability of one such economic evidence base-the English Tobacco Return on Investment (ROI) tool-to other EU member states.Methods and analysis: EQUIPT is a multicentre, interdisciplinary comparative effectiveness research study in public health. The Tobacco ROI tool already developed in England by the National Institute for Health and Care Excellence (NICE) will be adapted to meet the needs of European decision-makers, following transferability criteria. Stakeholders' needs and intention to use ROI tools in sample countries (Germany, Hungary, Spain and the Netherlands) will be analysed through interviews and surveys and complemented by secondary analysis of the contextual and other factors. Informed by this contextual analysis, the next phase will develop country-specific ROI tools in sample countries using a mix of economic modelling and Visual Basic programming. The results from the country-specific ROI models will then be compared to derive policy proposals that are transferable to other EU states, from which a centralised web tool will be developed. This will then be made available to stakeholders to cater for different decision-making contexts across Europe.Ethics and dissemination: The Brunel University Ethics Committee and relevant authorities in each of the participating countries approved the protocol. EQUIPT has a dedicated work package on dissemination, focusing on stakeholders' communication needs. Results will be disseminated via peer-reviewed publications, e-learning resources and policy briefs.

AB - Introduction: Tobacco smoking claims 700 000 lives every year in Europe and the cost of tobacco smoking in the EU is estimated between €98 and €130 billion annually; direct medical care costs and indirect costs such as workday losses each represent half of this amount. Policymakers all across Europe are in need of bespoke information on the economic and wider returns of investing in evidence-based tobacco control, including smoking cessation agendas. EQUIPT is designed to test the transferability of one such economic evidence base-the English Tobacco Return on Investment (ROI) tool-to other EU member states.Methods and analysis: EQUIPT is a multicentre, interdisciplinary comparative effectiveness research study in public health. The Tobacco ROI tool already developed in England by the National Institute for Health and Care Excellence (NICE) will be adapted to meet the needs of European decision-makers, following transferability criteria. Stakeholders' needs and intention to use ROI tools in sample countries (Germany, Hungary, Spain and the Netherlands) will be analysed through interviews and surveys and complemented by secondary analysis of the contextual and other factors. Informed by this contextual analysis, the next phase will develop country-specific ROI tools in sample countries using a mix of economic modelling and Visual Basic programming. The results from the country-specific ROI models will then be compared to derive policy proposals that are transferable to other EU states, from which a centralised web tool will be developed. This will then be made available to stakeholders to cater for different decision-making contexts across Europe.Ethics and dissemination: The Brunel University Ethics Committee and relevant authorities in each of the participating countries approved the protocol. EQUIPT has a dedicated work package on dissemination, focusing on stakeholders' communication needs. Results will be disseminated via peer-reviewed publications, e-learning resources and policy briefs.

UR - http://www.scopus.com/inward/record.url?scp=84912035793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912035793&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2014-006945

DO - 10.1136/bmjopen-2014-006945

M3 - Article

VL - 4

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 11

M1 - e006945

ER -